Blockchain Registration Transaction Record

Telomir Pharmaceuticals Receives $3M Investment, Advances Key Drug Candidates

Telomir Pharmaceuticals receives $3 million investment from The Bayshore Trust, advancing key drug candidates Telomir-1 and Telomir-Ag2. CEO Erez Aminov emphasizes shareholder-friendly financing. IND submission for Telomir-1 planned by year-end. Visit the press release for more details.

Telomir Pharmaceuticals Receives $3M Investment, Advances Key Drug Candidates

This news matters as Telomir Pharmaceuticals secures a significant equity investment, showcasing confidence in its drug development pipeline. The company's focus on age-reversal and combating drug-resistant infections could have far-reaching implications for the healthcare industry and potential investors.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x1496f12e4a11d44228932d41f93b88bb8ea7037f3761799d62945f5a04a6d79f
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintfastmcPm-d576f5460c9d37412ac76e85f019dc99